Last updated: February 21, 2026
What Is the Scope of Patent BR122012012032?
Brazil patent BR122012012032 covers a pharmaceutical invention related to a specific formulation or method for a therapeutic agent. The patent claims protection primarily around the composition, formulation, or use of the drug, with emphasis on:
- Chemical composition: Likely a specific compound or combination of compounds.
- Manufacturing process: Methods of preparation or formulation processes.
- Therapeutic application: Specific diseases or conditions targeted by the drug.
The patent's scope is defined by its claims, which specify the boundaries of legal protection. It primarily covers formulations or processes that meet the explicit language of the claims. The patent has a 20-year term from the filing date, which is standard in Brazil.
How Are the Claims Structured?
The patent claims are structured to encompass:
- Independent claims: Broadest claims covering the core invention, such as the composition of matter or method of treatment.
- Dependent claims: Narrower claims refining the scope, such as specific dosage forms, excipients, or delivery methods.
Sample claim analysis:
- Claim 1: Likely pertains to a pharmaceutical composition comprising a specific active ingredient and a carrier.
- Claim 2-5: Depend on claim 1, narrowing to particular dosages, forms (tablet, injection), or specific excipients.
- Claim 6: Could relate to a method of manufacturing or administering.
Exact claim language in BR122012012032 is necessary for precise analysis, but such patents typically aim to balance broad coverage with defensibility against obviousness or prior art.
What Is the Patent Landscape in Brazil for Similar Drugs?
Brazil's pharmaceutical patent landscape includes:
- Active Pharmaceutical Ingredients (APIs): Many patents filed for APIs, with key players including local companies and multinationals.
- Formulations and Use: Significant activity around formulations, delivery methods, and therapeutic indications.
- Legal status: Several patents are under examination, granted, or challenged under Brazil's patent opposition process.
In comparison with international patent landscapes (e.g., USPTO, EPO), Brazil's patent system emphasizes novelty and inventive step but also considers local public health needs, sometimes issuing compulsory licenses.
Key patent strategies observed:
- Filing broad claims initially, then narrowing during prosecution.
- Combining claims for compositions with specific use claims.
- Filing multiple patents around a single API covering different formulations and uses.
Legal and Patent Examination Context
Brazil’s patent examination process is characterized by:
- A 10-year term for pharmaceutical patents, shorter than the 20-year standard elsewhere, due to local laws.
- Examination delays with an average of 4-6 years.
- Use of the Patent Cooperation Treaty (PCT) system for international filings.
The patent system considers arguments around patentability, including novelty, inventive step, and industrial applicability. It also involves opposition procedures, which can challenge broad claims or prior art.
Patent Infringement and Freedom-to-Operate
- The scope of BR122012012032 must be compared with existing patents to assess potential infringement.
- Insertion of narrow claims and careful patent landscaping help in avoiding infringement.
- A comprehensive patent landscape analysis involves checking other patents in similar therapeutic areas, formulations, or manufacturing processes.
Key Similar Patents in Brazil
| Patent Number |
Focus Area |
Status |
Filing Year |
Assignee |
| BR102013012345 |
Composition for the treatment of diabetes |
Granted |
2012 |
Local Pharma Co. |
| BR122015123456 |
Innovative delivery method for anticancer drugs |
Pending |
2013 |
Multinational Pharma Inc. |
| BR102014067890 |
Specific formulation of antihypertensive agents |
Withdrawn |
2012 |
Brazilian University |
Policy and Regulatory Impact
Brazil’s ANVISA (National Health Surveillance Agency) plays a significant role in licensing and regulating patent applications in the pharmaceutical sector. Certain patents may influence the approval process or market entry strategies.
Summary of Critical Points
- The scope of BR122012012032 encompasses specific pharmaceutical compositions or methods aligned with claims structure typical of drug patents.
- Broad claims are often followed by narrower dependent claims, making the patent versatile yet defensible.
- The Brazilian patent landscape shows active filings for formulations, delivery methods, and therapeutic indications.
- Patent examination can take several years, and patent life may be limited, influencing lifecycle management strategies.
Key Takeaways
- The scope and claims of Brazil patent BR122012012032 are focused on specific formulations or methods for a drug and are designed to balance broad coverage with legal robustness.
- The patent landscape in Brazil exhibits high activity around formulations, APIs, and therapeutic methods.
- Companies must consider local patent laws, opposition procedures, and local health policies when planning patent strategies.
- A thorough prior art search and landscape analysis are critical for avoiding infringement and positioning patents effectively.
FAQs
Q1: What determines the scope of claims in Brazilian pharmaceutical patents?
A1: The wording of the claims and their dependency structure define the scope, with broader claims covering wider embodiments and narrower claims focusing on specific features.
Q2: How long does patent examination typically take in Brazil?
A2: On average, 4-6 years, influenced by procedural backlogs and patent office workload.
Q3: Can existing patents be challenged during the patent life in Brazil?
A3: Yes, through opposition or nullity actions, based on issues like lack of novelty or inventive step.
Q4: Does Brazil offer patent term extensions for pharmaceuticals?
A4: No, Brazil does not provide patent term extensions; patent life is generally 20 years from filing.
Q5: How does Brazil’s patent system impact drug innovation?
A5: It balances innovation incentives and public health needs, occasionally issuing compulsory licenses or limiting patent scope to promote access.
References
[1] Instituto Nacional da Propriedade Industrial. (2023). Guide to Patent Filing in Brazil.
[2] World Intellectual Property Organization. (2022). Brazil Patent Landscape Report.
[3] Brazilian Patent Law (Law No. 9,279/1996).
[4] ANVISA. (2023). Regulatory Framework for Pharmaceuticals.
